JP Morgan Chase’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.72M | Buy |
|
|||||
|
2025
Q2 | $636K | Sell |
|
|||||
|
2025
Q1 | $26.5M | Buy |
|
|||||
|
2024
Q4 | $3.38M | Buy |
|
|||||
|
2024
Q3 | $1.81M | Buy |
|
|||||
|
2024
Q2 | $1.4M | Sell |
|
|||||
|
2024
Q1 | $3.67M | Sell |
|
|||||
|
2023
Q4 | $2.49M | Buy |
|
|||||
|
2023
Q3 | $1.69M | Buy |
|
|||||
|
2023
Q2 | $1.19M | Buy |
|
|||||
|
2023
Q1 | $1M | Sell |
|
|||||
|
2022
Q4 | $1.99M | Buy |
|
|||||
|
2022
Q3 | $669K | Buy |
|
|||||
|
2022
Q2 | $420K | Sell |
|
|||||
|
2022
Q1 | $2.04M | Buy |
|
|||||
|
2021
Q4 | $1.94M | Buy |
|
|||||
|
2021
Q3 | $415K | Buy |
|
|||||
|
2021
Q2 | $393K | Buy |
|
|||||
|
2021
Q1 | $393K | Buy |
|
|||||
|
2020
Q4 | $411K | Buy |
|
|||||
|
2020
Q3 | $102K | Buy |
|
|||||
|
2020
Q2 | $88K | Buy |
|